A chain of custody form documents the unbroken, recorded transfer of a biological specimen — urine or oral fluid — from collection through laboratory analysis. Under AS 4308:2023 and AS 4760:2019, chain of custody is mandatory for any workplace drug test result that may be used in an employment decision. Without it, the result cannot be confirmed as a positive and cannot support disciplinary action.
What the chain of custody form actually records
The form itself is deceptively straightforward. It records who the donor is, when and where the collection occurred, who collected the specimen, what was collected (volume, temperature, any anomalies), how it was sealed and labelled, and every subsequent transfer — from collector to courier, courier to laboratory, laboratory accessioning through analysis and final disposal.
Every transfer requires a signature, a date, and a time. The specimen container label must match the form exactly. The donor signs to confirm the specimen was collected, sealed, and labelled in their presence. If any of these steps are missing, the specimen is a rejected collection.
A typical CoC form under AS 4308:2023 captures seven specific data points at collection:
Donor identity verification (photo ID type and number)
Collection date, time, and location
Collector name, signature, and accreditation number
Specimen ID number (pre-printed, matching container label)
Specimen temperature at collection (acceptable: 32–38°C)
Volume collected and any remarks on collection difficulty
Donor signature and any donor statement or refusal note
AS 4308:2023 and AS 4760:2019 — what the standards actually require
Two standards govern chain of custody in Australian workplace drug testing, and they apply to different specimen types. Both are referenced in Safe Work Australia's national guidance on managing alcohol and other drugs in the workplace.
| Standard | Specimen | Key CoC requirements |
|---|---|---|
| AS 4308:2023 | Urine | Full CoC from collection to NATA lab; split specimen option; temperature check; MRO review of non-negatives; 12-month specimen retention after confirmed positive |
| AS 4760:2019 | Oral fluid | Full CoC from collection to NATA lab; device lot number recorded; donor observation period (10 min pre-collection); MRO review mandatory; oral fluid not split — single specimen only |
A critical point that many employers miss: both standards require that any non-negative result from a NATA-accredited laboratory must be reviewed by a Medical Review Officer (MRO) before it is communicated to the employer. The MRO contacts the donor to determine whether there is a legitimate medical explanation — a prescription medication, a documented medical condition — that would explain the finding.
Only after MRO review is a confirmed positive communicated to the employer as a "non-negative — no valid medical explanation." An employer who acts on a laboratory result before MRO review is acting on incomplete information and has bypassed the process the standard requires.
The end-to-end process — from collection to employer outcome
Understanding the full process helps you identify exactly where the CoC must be maintained and where failures most commonly occur.
Pre-collection
Donor identity is verified. For urine, the donor is asked to remove outer clothing and empty pockets before entering the collection area. Tap water in the collection room is turned off or blue-dyed. The collection kit (pre-printed with unique specimen ID) is opened in the donor's presence. The CoC form is initiated.
Collection
The donor provides the specimen. For urine: minimum 30 mL into the specimen cup. Temperature is checked immediately (32–38°C acceptable). For oral fluid: a 10-minute abstention period precedes collection; the swab device is placed under the tongue or between cheek and gum per device instructions.
Sealing and signing
The specimen is poured into the transport tube(s) in the donor's presence. The tamper-evident seals are applied. Both the collector and donor sign and date the CoC form. If the donor refuses to sign, this is documented — a refusal to sign does not invalidate the collection, but must be noted.
Transport to laboratory
The sealed specimen and completed CoC form are packaged. Each transfer — collector to courier, courier to lab receiving — is documented on the CoC form with signature, date, and time. The laboratory accessioner checks that the form and specimen label match before accepting the specimen.
Laboratory analysis
The NATA-accredited laboratory conducts immunoassay screening. Any non-negative result proceeds to confirmatory analysis by gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–tandem mass spectrometry (LC-MS/MS). Cutoff concentrations are prescribed in AS 4308:2023 and AS 4760:2019.
MRO review
For any confirmed non-negative, the MRO contacts the donor to determine if there is a legitimate medical explanation. The MRO reviews prescription documentation. If there is no valid medical explanation, the MRO reports a confirmed non-negative to the employer. If there is a valid explanation, the result is reported as negative.
Employer outcome
The employer receives a fitness-for-work outcome, not a laboratory report. The employer's D&A policy governs what happens next — stand-down, return to safety-sensitive duties pending assessment, support referral, or formal disciplinary process consistent with the Fair Work Act 2009.
Where chain of custody fails in practice
After 26 years reviewing OHS programs, the same failure modes appear repeatedly. None of them are exotic. Most are preventable with adequate collector training and process discipline.
Specimen sealed outside the donor's direct observation
The donor must witness the sealing. If the collector leaves the room with the unsealed specimen — even briefly — the CoC is broken. The donor can legitimately challenge the result on the basis that they cannot confirm the specimen was not tampered with.
Temperature outside the acceptable range without documentation
A urine specimen outside 32–38°C at collection is a red flag for substitution. If the temperature is outside range and no deviation report is completed, the laboratory cannot assess whether the specimen is genuine. The collection should be documented as temperature-anomalous and a second collection initiated.
Specimen ID mismatch between label and CoC form
Pre-printed collection kits have matching IDs on the container label and the CoC form. If these numbers do not match — transcription error, wrong kit used — the laboratory rejects the collection. This is a process error, not a donor issue, but it costs the employer a repeat collection and potentially a safety gap.
Acting on POCT non-negative without confirmatory laboratory testing
A point-of-collection test is a screen. A screen is not a confirmed result. Standing down or dismissing an employee on the basis of a POCT non-negative alone — without completed CoC confirmatory laboratory testing — has been the basis of successful unfair dismissal claims in the Fair Work Commission.
No MRO review before communicating result to employer
The MRO step is not administrative overhead — it is built into the standard because false positives exist, prescription medications generate genuine non-negatives, and the employer is not qualified to assess medical explanations. Bypassing MRO review means the employer may be acting on a result that the standard would have classified as negative.
The legal context — WHS Act, Fair Work Act, and AS 4308:2023
The model Work Health and Safety Act 2011 (and its state and territory equivalents) requires the person conducting a business or undertaking (PCBU) to eliminate or minimise risks to health and safety, so far as reasonably practicable. For safety-sensitive roles — mining, rail, aviation, heavy transport, construction, chemical processing — a defensible drug testing program is part of that obligation. The program is only defensible if the chain of custody is maintained throughout.
Under the Fair Work Act 2009, an employer must have a valid reason for dismissal, and the reason must be substantiated by admissible evidence. A drug test result without a complete CoC record is not admissible evidence. The Fair Work Commission has set aside dismissals on CoC grounds in mining, transport, and construction contexts — not because the employee was not impaired, but because the process was not followed.
The Privacy Act 1988 (Cth) also applies. Drug test results are health information — sensitive information under the Australian Privacy Principles. The chain of custody record is a health record and must be handled accordingly: stored securely, access-controlled, retained for the appropriate period, and not disclosed beyond those with a legitimate need to know.
Key legislative references: Work Health and Safety Act 2011 (Cth and state/territory equivalents) · Fair Work Act 2009 (Cth) · Privacy Act 1988 (Cth) · Disability Discrimination Act 1992 (Cth) · AS 4308:2023 · AS 4760:2019
Frequently asked questions
What is a chain of custody form in drug testing?
A chain of custody (CoC) form is the paper trail that documents the continuous, unbroken control of a biological specimen — urine or oral fluid — from the moment it is collected from the donor through transport, laboratory receipt, analysis, and final disposal. Under AS 4308:2023 (urine) and AS 4760:2019 (oral fluid), CoC documentation is not optional — it is a mandatory requirement of a legally defensible workplace drug test in Australia. Each transfer of custody must be recorded with date, time, and the identity of the person transferring and receiving the sample. A chain of custody that cannot be demonstrated renders the result non-defensible in a WHS investigation, Fair Work proceeding, or coronial inquiry.
What Australian standards govern chain of custody in workplace drug testing?
Two standards apply depending on specimen type. AS 4308:2023 (Procedures for specimen collection and the detection and quantitation of drugs of abuse in urine) governs urine testing, including chain of custody requirements from collection to NATA-accredited laboratory analysis. AS 4760:2019 (Procedures for specimen collection and the detection and quantitation of drugs in oral fluid) governs oral fluid testing. Both standards specify the documentation requirements, tamper-evident packaging, temperature storage requirements, and the role of the Medical Review Officer (MRO) in reviewing non-negative confirmed results before any outcome is communicated to the employer. Non-compliance with either standard compromises the defensibility of the entire test.
Who can collect a sample for a chain of custody drug test in Australia?
Collection under AS 4308:2023 or AS 4760:2019 must be conducted by a trained collection officer who has completed approved training in specimen collection procedures consistent with the standard. This is not general nursing or OHS training — it is specimen-specific collection training. The collector is responsible for verifying donor identity, completing the CoC form, observing the collection process for temperature and volume compliance (urine), sealing the specimen in the presence of the donor, obtaining the donor's signature, and ensuring the completed CoC form accompanies the specimen to the laboratory. Any deviation from procedure — an unsigned form, a specimen sealed without the donor present, a temperature outside the accepted range — must be documented as a rejected collection.
What happens if the chain of custody is broken?
A broken chain of custody — any undocumented transfer, an unsealed specimen, a specimen arriving at the laboratory without a completed CoC form, or a discrepancy between the form and the specimen label — renders the test result non-reportable as a confirmed positive. The laboratory is required to document the discrepancy and report a rejected collection. The employer cannot act on a rejected collection result. In practice, this means the collection must be repeated. In a safety-sensitive environment, a broken CoC that prevents action on a true positive is a serious safety failure — which is why collector training and process compliance, not just the test itself, are the real risk management investment.
Does an instant (point-of-collection) drug test require chain of custody?
An initial screen using a point-of-collection testing (POCT) device does not in itself require full laboratory chain of custody — POCT is defined under AS 4308:2023 as a screening test only. However, any non-negative POCT result must be confirmed by a NATA-accredited laboratory using a full chain of custody collection before any adverse employment action can be taken. An unconfirmed POCT non-negative result is not a positive result — it is an indication for confirmatory testing. Employers who act on unconfirmed POCT results — standing someone down, dismissing them — without completing the confirmatory laboratory process under full CoC are acting on inadmissible evidence and creating serious unfair dismissal and discrimination exposure.
How long should chain of custody records be retained?
There is no single prescribed retention period under AS 4308:2023 or AS 4760:2019 for CoC records, but Australian legal practice recommends a minimum of 7 years given the limitation periods for unfair dismissal (Fair Work Act 2009), discrimination complaints (relevant state and federal legislation), and civil liability. For safety-critical roles in regulated industries (mining, rail, aviation, maritime), retain for the duration of employment plus 7 years. Where a test result has been the subject of a disciplinary action, dismissal, or legal challenge, retain the CoC documentation for the full duration of any proceedings plus 7 years from final resolution. Records must be stored securely with access limited to authorised personnel.
Drug & Alcohol Testing — Service Overview
OccuSpan's AS 4308:2023 and AS 4760:2019 compliant D&A testing programs for Australian workplaces.
Fitness for Work Assessment
When a non-negative result triggers a fitness assessment — process, legal basis, and documentation.
Pre-Employment Screening
D&A testing as a component of a compliant pre-employment screening program.
Managing Psychosocial Hazards at Work
Fatigue, substance use, and psychological risk — integrated management under ISO 45003:2021.
OccuSpan D&A Testing Module
Chain of custody — managed end to end
OccuSpan manages the full AS 4308:2023 and AS 4760:2019 process — trained collection officers, tamper-evident kits, NATA-accredited laboratory partnerships, MRO review, and documented outcomes — so your chain of custody is complete and your results are defensible.
See the D&A testing program